1 Market Overview
1.1 Pembrolizumab Introduction
1.2 Market Analysis by Type
1.2.1 50mg Injection
1.2.2 100mg Injection
1.3 Market Analysis by Applications
1.3.1 Advanced Melanoma
1.3.2 Head and Neck Squamous Cell Carcinoma (HNSCC)
1.3.3 Unresectable or Metastatic Solid Tumor
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2015-2025)
1.4.1.2 Canada Market States and Outlook (2015-2025)
1.4.1.3 Mexico Market States and Outlook (2015-2025)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2015-2025)
1.4.2.2 France Market States and Outlook (2015-2025)
1.4.2.3 UK Market States and Outlook (2015-2025)
1.4.2.4 Russia Market States and Outlook (2015-2025)
1.4.2.5 Italy Market States and Outlook (2015-2025)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2015-2025)
1.4.3.2 Japan Market States and Outlook (2015-2025)
1.4.3.3 Korea Market States and Outlook (2015-2025)
1.4.3.4 India Market States and Outlook (2015-2025)
1.4.3.5 Southeast Asia Market States and Outlook (2015-2025)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2015-2025)
1.4.4.2 Egypt Market States and Outlook (2015-2025)
1.4.4.3 Saudi Arabia Market States and Outlook (2015-2025)
1.4.4.4 South Africa Market States and Outlook (2015-2025)
1.4.4.5 Turkey Market States and Outlook (2015-2025)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Business Overview
2.1.2 Pembrolizumab Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck Pembrolizumab Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
3 Global Pembrolizumab Sales, Revenue, Market Share and Competition by Manufacturer (2017-2019)
3.1 Global Pembrolizumab Sales and Market Share by Manufacturer (2017-2019)
3.2 Global Pembrolizumab Revenue and Market Share by Manufacturer (2017-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Pembrolizumab Manufacturer Market Share in 2019
3.3.2 Top 6 Pembrolizumab Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Pembrolizumab Market Analysis by Regions
4.1 Global Pembrolizumab Sales, Revenue and Market Share by Regions
4.1.1 Global Pembrolizumab Sales and Market Share by Regions (2015-2019)
4.1.2 Global Pembrolizumab Revenue and Market Share by Regions (2015-2019)
4.2 North America Pembrolizumab Sales and Growth Rate (2015-2019)
4.3 Europe Pembrolizumab Sales and Growth Rate (2015-2019)
4.4 Asia-Pacific Pembrolizumab Sales and Growth Rate (2015-2019)
4.5 South America Pembrolizumab Sales and Growth Rate (2015-2019)
4.6 Middle East and Africa Pembrolizumab Sales and Growth Rate (2015-2019)
5 North America Pembrolizumab by Country
5.1 North America Pembrolizumab Sales, Revenue and Market Share by Country
5.1.1 North America Pembrolizumab Sales and Market Share by Country (2015-2019)
5.1.2 North America Pembrolizumab Revenue and Market Share by Country (2015-2019)
5.2 United States Pembrolizumab Sales and Growth Rate (2015-2019)
5.3 Canada Pembrolizumab Sales and Growth Rate (2015-2019)
5.4 Mexico Pembrolizumab Sales and Growth Rate (2015-2019)
6 Europe Pembrolizumab by Country
6.1 Europe Pembrolizumab Sales, Revenue and Market Share by Country
6.1.1 Europe Pembrolizumab Sales and Market Share by Country (2015-2019)
6.1.2 Europe Pembrolizumab Revenue and Market Share by Country (2015-2019)
6.2 Germany Pembrolizumab Sales and Growth Rate (2015-2019)
6.3 UK Pembrolizumab Sales and Growth Rate (2015-2019)
6.4 France Pembrolizumab Sales and Growth Rate (2015-2019)
6.5 Russia Pembrolizumab Sales and Growth Rate (2015-2019)
6.6 Italy Pembrolizumab Sales and Growth Rate (2015-2019)
7 Asia-Pacific Pembrolizumab by Country
7.1 Asia-Pacific Pembrolizumab Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Pembrolizumab Sales and Market Share by Country (2015-2019)
7.1.2 Asia-Pacific Pembrolizumab Revenue and Market Share by Country (2015-2019)
7.2 China Pembrolizumab Sales and Growth Rate (2015-2019)
7.3 Japan Pembrolizumab Sales and Growth Rate (2015-2019)
7.4 Korea Pembrolizumab Sales and Growth Rate (2015-2019)
7.5 India Pembrolizumab Sales and Growth Rate (2015-2019)
7.6 Southeast Asia Pembrolizumab Sales and Growth Rate (2015-2019)
8 South America Pembrolizumab by Country
8.1 South America Pembrolizumab Sales, Revenue and Market Share by Country
8.1.1 South America Pembrolizumab Sales and Market Share by Country (2015-2019)
8.1.2 South America Pembrolizumab Revenue and Market Share by Country (2015-2019)
8.2 Brazil Pembrolizumab Sales and Growth Rate (2015-2019)
8.3 Argentina Pembrolizumab Sales and Growth Rate (2015-2019)
8.4 Colombia Pembrolizumab Sales and Growth Rate (2015-2019)
9 Middle East and Africa Pembrolizumab by Countries
9.1 Middle East and Africa Pembrolizumab Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Pembrolizumab Sales and Market Share by Country (2015-2019)
9.1.2 Middle East and Africa Pembrolizumab Revenue and Market Share by Country (2015-2019)
9.2 Saudi Arabia Pembrolizumab Sales and Growth Rate (2015-2019)
9.3 Turkey Pembrolizumab Sales and Growth Rate (2015-2019)
9.4 Egypt Pembrolizumab Sales and Growth Rate (2015-2019)
9.5 Nigeria Pembrolizumab Sales and Growth Rate (2015-2019)
9.6 South Africa Pembrolizumab Sales and Growth Rate (2015-2019)
10 Global Pembrolizumab Market Segment by Type
10.1 Global Pembrolizumab Sales, Revenue and Market Share by Type (2015-2019)
10.1.1 Global Pembrolizumab Sales and Market Share by Type (2015-2019)
10.1.2 Global Pembrolizumab Revenue and Market Share by Type (2015-2019)
10.2 50mg Injection Sales Growth and Price
10.2.1 Global 50mg Injection Sales Growth (2015-2019)
10.2.2 Global 50mg Injection Price (2015-2019)
10.3 100mg Injection Sales Growth and Price
10.3.1 Global 100mg Injection Sales Growth (2015-2019)
10.3.2 Global 100mg Injection Price (2015-2019)
11 Global Pembrolizumab Market Segment by Application
11.1 Global Pembrolizumab Sales Market Share by Application (2015-2019)
11.2 Advanced Melanoma Sales Growth (2015-2019)
11.3 Head and Neck Squamous Cell Carcinoma (HNSCC) Sales Growth (2015-2019)
11.4 Unresectable or Metastatic Solid Tumor Sales Growth (2015-2019)
11.5 Other Sales Growth (2015-2019)
12 Pembrolizumab Market Forecast (2020-2025)
12.1 Global Pembrolizumab Sales, Revenue and Growth Rate (2020-2025)
12.2 Pembrolizumab Market Forecast by Regions (2020-2025)
12.2.1 North America Pembrolizumab Market Forecast (2020-2025)
12.2.2 Europe Pembrolizumab Market Forecast (2020-2025)
12.2.3 Asia-Pacific Pembrolizumab Market Forecast (2020-2025)
12.2.4 South America Pembrolizumab Market Forecast (2020-2025)
12.2.5 Middle East and Africa Pembrolizumab Market Forecast (2020-2025)
12.3 Pembrolizumab Market Forecast by Type (2020-2025)
12.3.1 Global Pembrolizumab Sales Forecast by Type (2020-2025)
12.3.2 Global Pembrolizumab Market Share Forecast by Type (2020-2025)
12.4 Pembrolizumab Market Forecast by Application (2020-2025)
12.4.1 Global Pembrolizumab Sales Forecast by Application (2020-2025)
12.4.2 Global Pembrolizumab Market Share Forecast by Application (2020-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
